254 results on '"Cheng, Alfred S. L."'
Search Results
2. Integrative analysis reveals associations between oral microbiota dysbiosis and host genetic and epigenetic aberrations in oral cavity squamous cell carcinoma
3. Aberrant cholesterol metabolic signaling impairs antitumor immunosurveillance through natural killer T cell dysfunction in obese liver
4. The molecular classification of cancer‐associated fibroblasts on a pan‐cancer single‐cell transcriptional atlas
5. NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway
6. STK3 promotes gastric carcinogenesis by activating Ras-MAPK mediated cell cycle progression and serves as an independent prognostic biomarker
7. FGF18–FGFR2 signaling triggers the activation of c-Jun–YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential
8. A unified framework for integrative study of heterogeneous gene regulatory mechanisms
9. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis
10. Gastric cancer: genome damaged by bugs
11. FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p
12. Data from Epigenetic Silencing Mediated through Activated PI3K/AKT Signaling in Breast Cancer
13. Supplementary Figures 1-6, Tables 1-15, Methods from Epigenetic Silencing Mediated through Activated PI3K/AKT Signaling in Breast Cancer
14. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis
15. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma
16. The oncogenic role of Epstein–Barr virus‐encoded microRNAs in Epstein–Barr virus‐associated gastric carcinoma
17. The physiological role of Motin family and its dysregulation in tumorigenesis
18. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
19. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.
20. Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesis
21. Liver Immune Microenvironment and Metastasis from Colorectal Cancer-Pathogenesis and Therapeutic Perspectives
22. Multi-omic analysis suggests tumor suppressor genes evolved specific promoter features to optimize cancer resistance
23. Overexpression of HMGA1 deregulates tumor growth via cdc25A and alters migration/invasion through a cdc25A-independent pathway in medulloblastoma
24. The Intersection between Oral Microbiota, Host Gene Methylation and Patient Outcomes in Head and Neck Squamous Cell Carcinoma
25. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth
26. Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer
27. Inhibitory Role of Peroxisome Proliferator-Activated Receptor Gamma in Hepatocarcinogenesis in Mice and in Vitro
28. Expression of a cyclo-oxygenase-2 transgene in murine liver causes hepatitis
29. A mixture model-based discriminate analysis for identifying ordered transcription factor binding site pairs in gene promoters directly regulated by estrogen receptor-α
30. Expression of HBx and COX-2 in chronic hepatitis B, cirrhosis and hepatocellular carcinoma: implication of HBx in upregulation of COX-2
31. ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy
32. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
33. E2F6 functions as a competing endogenous RNA, and transcriptional repressor, to promote ovarian cancer stemness
34. Targeting the miR-630/YAP1/ERK feedback loop in epidermal growth factor receptor-mutated lung adenocarcinomas
35. FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p
36. Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesis
37. New guidelines for DNA methylome studies regarding 5-hydroxymethylcytosine for understanding transcriptional regulation
38. PIEZO1 functions as a potential oncogene by promoting cell proliferation and migration in gastric carcinogenesis
39. SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis
40. The oncogenic role of Epstein-Barr virus-encoded microRNAs in Epstein-Barr virus-associated gastric carcinoma
41. Reconstruction of enhancer–target networks in 935 samples of human primary cells, tissues and cell lines
42. IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis
43. A transcriptional-microRNA network for β-catenin-driven stemness in hepatocellular carcinoma
44. NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors?
45. Gender Differences in Adipocyte Metabolism and Liver Cancer Progression
46. Epigenetic silencing of the NR4A3 tumor suppressor, by aberrant JAK/STAT signaling, predicts prognosis in gastric cancer
47. A novel role of hepatic epithelial transforming growth factor-β signaling in cholangiocarcinogenesis
48. Dysregulated Lysine Acetyltransferase 2B Promotes Inflammatory Bowel Disease Pathogenesis Through Transcriptional Repression of Interleukin-10
49. miR-508-3p concordantly silences NFKB1 and RELA to inactivate canonical NF-κB signaling in gastric carcinogenesis
50. The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.